In prostate cancer, ovarian cancer and colorectal cancer MAGL has been shown to be a key enzyme in the lipid metabolism network, promotes tumor progression by supplying FFA for β-oxidation, provides components to build cell structures and effector molecules which are involved in cell proliferation, invasion, apoptosis resistance and stemness. This evidence concerns the gene MGLL and neoplasm.